𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Killer dendritic cells and their potential for cancer immunotherapy

✍ Scribed by Nicolas Larmonier; Jennifer Fraszczak; Daniela Lakomy; Bernard Bonnotte; Emmanuel Katsanis

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
489 KB
Volume
59
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Immunotherapy with dendritic cells for p
Immunotherapy with dendritic cells for prostate cancer
✍ Anna-Katharina Thomas-Kaskel; Cornelius F. Waller; Wolfgang Schultze-Seemann; He πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 152 KB

## Abstract Radical prostatectomy for prostate cancer is followed by PSA recurrence in up to 40% of patients. One third of patients with biochemical relapse progress to uncurable metastatic disease. Therefore, alternative treatment modalities are needed both in the situation of PSA recurrence and i

Exploiting dendritic cells for cancer im
Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells
✍ Karine Breckpot; Carlo Heirman; Bart Neyns; Kris Thielemans πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 579 KB

## Abstract Dendritic cells (DCs) are pivotal regulators of immune reactivity and immune tolerance. The observation that DCs can recruit naive T cells has invigorated cancer immunology and led to the proposal of DCs as the basis for vaccines designed for the treatment of cancer. Designing effective

Lentivirally transduced dendritic cells
Lentivirally transduced dendritic cells as a tool for cancer immunotherapy
✍ Karine Breckpot; Melissa Dullaers; Aude Bonehill; Sonja Van Meirvenne; Carlo Hei πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 348 KB

## Abstract ## Background Dendritic cells (DC) are the professional antigen‐presenting cells of the immune system, fully equipped to prime naive T cells and thus essential components for cancer immunotherapy. ## Methods We tested the influence of several elements (cPPT, trip, WPRE, SIN) on the t

Immunotherapy of cancer with lymphokines
Immunotherapy of cancer with lymphokines and lymphokine-activated killer cells
✍ John W. Yarbro πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 996 KB

Our expanding knowledge of the immune system has provided a basis of rationality for immunotherapy . Some non-specific immunotherapy has achieved the status of standard treatment: interferon in hairy cell leukemia and chronic myelogenous leukemia, BCG in bladder cancer, and levamisole in colon cance